These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

335 related articles for article (PubMed ID: 12669378)

  • 1. Therapeutic options for diseases due to potential viral agents of bioterrorism.
    Bronze MS; Greenfield RA
    Curr Opin Investig Drugs; 2003 Feb; 4(2):172-8. PubMed ID: 12669378
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recognition and management of bioterrorism infections.
    O'Brien KK; Higdon ML; Halverson JJ
    Am Fam Physician; 2003 May; 67(9):1927-34. PubMed ID: 12751654
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Viral hemorrhagic fever--Ebola hemorrhagic fever, Marburg disease and Lassa fever].
    Hotta H
    Rinsho Byori; 1998 Jul; 46(7):651-5. PubMed ID: 9721531
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [How to treat a patient with indications for an infectious viral hemorrhagic fever].
    Visser LG; Schippers EF; Swaan CM; van den Broek PJ
    Ned Tijdschr Geneeskd; 2002 Nov; 146(46):2183-8. PubMed ID: 12467160
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vaccines against biologic agents: uses and developments.
    Ales NC; Katial RK
    Respir Care Clin N Am; 2004 Mar; 10(1):123-46. PubMed ID: 15062232
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of treatment strategies to combat Ebola and Marburg viruses.
    Paragas J; Geisbert TW
    Expert Rev Anti Infect Ther; 2006 Feb; 4(1):67-76. PubMed ID: 16441210
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ebola hemorrhagic fever in the era of bioterrorism.
    Polesky A; Bhatia G
    Semin Respir Infect; 2003 Sep; 18(3):206-15. PubMed ID: 14505282
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The potential role of viral pathogens as agents of bioterrorism.
    Bronze MS; Voskuhl GW; Machado LJ; Greenfield RA
    J Okla State Med Assoc; 2003 Jan; 96(1):29-33. PubMed ID: 12632851
    [No Abstract]   [Full Text] [Related]  

  • 9. [Practical strategies against bioterrorism].
    Matsumoto T
    Nihon Rinsho; 2007 Dec; 65(12):2363-73. PubMed ID: 18069284
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Viral exanthems in the tropics.
    Carneiro SC; Cestari T; Allen SH; Ramos e-Silva M
    Clin Dermatol; 2007; 25(2):212-20. PubMed ID: 17350501
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular and cell biology of the prototypic arenavirus LCMV: implications for understanding and combating hemorrhagic fever arenaviruses.
    de la Torre JC
    Ann N Y Acad Sci; 2009 Sep; 1171 Suppl 1():E57-64. PubMed ID: 19751403
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The strategic plan for preparedness and response to bioterrorism in Korea].
    Hwang HS
    J Prev Med Public Health; 2008 Jul; 41(4):209-13. PubMed ID: 18664725
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Bioterrorism].
    Sata T
    Nihon Hoigaku Zasshi; 2005 Oct; 59(2):119-25. PubMed ID: 16296383
    [TBL] [Abstract][Full Text] [Related]  

  • 14. State-of-the-art therapeutic medical countermeasures for viral threat agents.
    Sampath A; Metz M; Stundick M; Larsen JC
    Biosecur Bioterror; 2011 Dec; 9(4):351-60. PubMed ID: 22053938
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Other viral bioweapons: Ebola and Marburg hemorrhagic fever.
    Salvaggio MR; Baddley JW
    Dermatol Clin; 2004 Jul; 22(3):291-302, vi. PubMed ID: 15207310
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bichat guidelines for the clinical management of haemorrhagic fever viruses and bioterrorism-related haemorrhagic fever viruses.
    Bossi P; Tegnell A; Baka A; Van Loock F; Hendriks J; Werner A; Maidhof H; Gouvras G;
    Euro Surveill; 2004 Dec; 9(12):E11-2. PubMed ID: 15677844
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Prophylaxis and treatment of viral infections. Part II--infections caused by RNA viruses].
    Strycharz M; Bartecka K; Polz-Dacewicz M
    Pol Merkur Lekarski; 2005 Feb; 18(104):233-5. PubMed ID: 17877139
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Viral hemorrhagic fever as a biological weapon].
    Robenshtok E; Laster M; Katz L; Brenner B; Sagi R
    Harefuah; 2002 May; 141 Spec No():96-9, 119. PubMed ID: 12170564
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antiviral treatment is more effective than smallpox vaccination upon lethal monkeypox virus infection.
    Stittelaar KJ; Neyts J; Naesens L; van Amerongen G; van Lavieren RF; Holý A; De Clercq E; Niesters HG; Fries E; Maas C; Mulder PG; van der Zeijst BA; Osterhaus AD
    Nature; 2006 Feb; 439(7077):745-8. PubMed ID: 16341204
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preventive and therapeutic approaches to viral agents of bioterrorism.
    Bronze MS; Greenfield RA
    Drug Discov Today; 2003 Aug; 8(16):740-5. PubMed ID: 12944096
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.